MiMedx Group
MDXG
236 hedge funds and large institutions have $1.13B invested in MiMedx Group in 2017 Q4 according to their latest regulatory filings, with 49 funds opening new positions, 77 increasing their positions, 71 reducing their positions, and 45 closing their positions.
22% more capital invested
Capital invested by funds: $924M → $1.13B (+$204M)
2% more funds holding
Funds holding: 232 → 236 (+4)
9% more first-time investments, than exits
New positions opened: 49 | Existing positions closed: 45
8% more repeat investments, than reductions
Existing positions increased: 77 | Existing positions reduced: 71
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
45% less call options, than puts
Call options by funds: $20.1M | Put options by funds: $36.6M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCM
Consonance Capital Management
New York
|
+$73.1M |
| 2 |
State Street
Boston,
Massachusetts
|
+$36M |
| 3 |
Balyasny Asset Management
Chicago,
Illinois
|
+$21.7M |
| 4 |
TA
Tiedemann Advisors
New York
|
+$17.2M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
+$16.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$20.5M |
| 2 |
GAM
Gotham Asset Management
New York
|
-$12.5M |
| 3 |
Barclays
London,
United Kingdom
|
-$9.08M |
| 4 |
PP
PDT Partners
New York
|
-$8.68M |
| 5 |
MCM
Matarin Capital Management
New York
|
-$8.25M |
MDXG Hedge Fund Activity: Q4 2017 in Review
236 of the 4,410 institutional investors tracked by Wall St. Rank reported a position in MiMedx Group (MDXG) for Q4 2017, worth a combined $1.13B — up 22% from $924M a quarter earlier.
Buyers outnumbered sellers: 49 funds opened new MDXG positions and 45 closed out — a net gain of 4 holders — while 77 added to existing stakes and 71 trimmed.
The largest buyer was Consonance Capital Management, opening a new position worth an estimated $73.1M. The largest seller was Macquarie Group, cutting an estimated $20.5M.
- 236 institutional investors held MiMedx Group (MDXG) as of Q4 2017, up from 232 in Q3 2017.
- Funds reported $1.13B of MiMedx Group stock for Q4 2017, up 22% quarter-over-quarter.
- 49 funds opened new MiMedx Group positions in Q4 2017 and 45 closed out, a net change of +4 holders.
- The largest MiMedx Group buyer in Q4 2017 was Consonance Capital Management, an estimated $73.1M added.
- The largest MiMedx Group seller in Q4 2017 was Macquarie Group, an estimated $20.5M sold.
Based on aggregated 13F filings for Q4 2017.